[1] Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418(6893):41-49. [2] Kögler G, Sensken S, Airey JA, et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med. 2004;200(2):123-135. [3] Zvaifler NJ, Marinova-Mutafchieva L, Adams G, et al. Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res. 2000;2(6):477-488. [4] Jiang Y, Vaessen B, Lenvik T, et al. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol. 2002; 30(8):896-904. [5] Gregory CA, Gunn WG, Peister A, et al. An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction.Anal Biochem. 2004;329(1):77-84. [6] Hayashi O, Katsube Y, Hirose M, et al. Comparison of osteogenic ability of rat mesenchymal stem cells from bone marrow, periosteum, and adipose tissue. Calcif Tissue Int. 2008;82(3):238-247. [7] Planat-Benard V, Silvestre JS, Cousin B, et al. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation. 2004;109(5):656-663. [8] Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies.Tissue Eng. 2001;7(2):211-228. [9] Safford KM, Safford SD, Gimble JM, et al. Characterization of neuronal/glial differentiation of murine adipose-derived adult stromal cells. Exp Neurol. 2004;187(2):319-328. [10] Dhar S, Yoon ES, Kachgal S, et al. Long-term maintenance of neuronally differentiated human adipose tissue-derived stem cells. Tissue Eng. 2007;13(11):2625-2632. [11] Safford KM, Hicok KC, Safford SD, et al. Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochem Biophys Res Commun. 2002; 294(2):371-379. [12] Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143-147. [13] Kamishina H, Farese JP, Storm JA, et al. The frequency, growth kinetics, and osteogenic/adipogenic differentiation properties of canine bone marrow stromal cells. In Vitro Cell Dev Biol Anim. 2008;44(10): 472-479. [14] Baksh D, Yao R, Tuan RS. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells. 2007; 25(6):1384-1392. [15] Yamaguchi S, Kuroda S, Kobayashi H, et al. The effects of neuronal induction on gene expression profile in bone marrow stromal cells (BMSC)--a preliminary study using microarray analysis. Brain Res. 2006;1087(1):15-27. [16] Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997;276(5309): 71-74. [17] Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976;4(5): 267-274. [18] Castro-Malaspina H, Gay RE, Resnick G, et al. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood. 1980;56(2):289-301. [19] Bab I, Ashton BA, Gazit D, et al. Kinetics and differentiation of marrow stromal cells in diffusion chambers in vivo. J Cell Sci. 1986;84:139-151. [20] Vellasamy S, Sandrasaigaran P, Vidyadaran S, et al. Isolation and characterisation of mesenchymal stem cells derived from human placenta tissue. World J Stem Cells. 2012;4(6):53-61. [21] Wang CH, Cherng WJ, Yang NI, et al. Late-outgrowth endothelial cells attenuate intimal hyperplasia contributed by mesenchymal stem cells after vascular injury. Arterioscler Thromb Vasc Biol. 2008;28(1): 54-60. [22] Loebinger MR, Kyrtatos PG, Turmaine M, et al. Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles. Cancer Res. 2009;69(23):8862-8867. [23] Sasportas LS, Kasmieh R, Wakimoto H, et al. Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy. Proc Natl Acad Sci U S A. 2009;106(12): 4822-4827. [24] Patel SA, Meyer JR, Greco SJ, et al. Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta. J Immunol. 2010;184(10): 5885-5894. [25] Menon LG, Picinich S, Koneru R, et al. Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells. Stem Cells. 2007; 25(2):520-528. [26] Studeny M, Marini FC, Champlin RE, et al. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res. 2002;62(13):3603-3608. [27] Bergfeld SA, DeClerck YA. Bone marrow-derived mesenchymal stem cells and the tumor microenvironment. Cancer Metastasis Rev. 2010;29(2):249-261. [28] Ishii G, Sangai T, Oda T, et al. Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction. Biochem Biophys Res Commun. 2003;309(1):232-240. [29] Nakamizo A, Marini F, Amano T, et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res. 2005;65(8): 3307-3318. [30] Lu YR, Yuan Y, Wang XJ, et al. The growth inhibitory effect of mesenchymal stem cells on tumor cells in vitro and in vivo. Cancer Biol Ther. 2008;7(2):245-251. [31] Secchiero P, Zorzet S, Tripodo C, et al. Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-Hodgkin's lymphoma xenografts. PLoS One. 2010;5(6):e11140. [32] Zhu Y, Sun Z, Han Q, et al. Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1. Leukemia. 2009;23(5):925-933. [33] Fukuchi Y, Nakajima H, Sugiyama D, et al. Human placenta-derived cells have mesenchymal stem/ progenitor cell potential. Stem Cells. 2004;22(5): 649-658. [34] Ilancheran S, Moodley Y, Manuelpillai U. Human fetal membranes: a source of stem cells for tissue regeneration and repair. Placenta. 2009;30(1):2-10. [35] Pevsner-Fischer M, Levin S, Zipori D. The origins of mesenchymal stromal cell heterogeneity. Stem Cell Rev. 2011;7(3):560-568. [36] 李鲁生,张涵,王成俊,等.骨髓间充质干细胞的分离方法和生物学特性[J].中国组织工程研究与临床康复, 2010, 14(10):1869-1873. [37] 韩立赤,胡静,戚孟春,等.密度梯度离心和贴壁法分离大鼠骨髓间充质干细胞增殖活性和成骨功能比较[J].现代口腔医学杂志,2005,19(3):287-290. [38] 武海军,银和平,李树文,等.密度梯度离心和贴壁筛选法分离培养兔骨髓间充质干细胞的形态学观察[J].中华临床医师杂志:电子版,2012,6(22):7261-7269. [39] 曾瑞霞,单伟,房艳,等.密度梯度离心法结合贴壁法体外分离培养大鼠骨髓间充质干细胞[J].解剖科学进展,2012, 18(5):438-441. [40] 张才龙,夏长所,蒋正尧.应用密度梯度离心和贴壁筛选法分离免骨髓间充质干细胞[J].中国组织工程研究与临床康复,2009,13(6):1181-1184. [41] 徐金霞,李家锋,韩建国,等.大鼠骨髓间充质干细胞生物学特性的研究[J].中国医药科学,2012,2(9):37-39. [42] 赵继学,王广义,张海玉,等.小鼠骨髓间充质干细胞的分离、培养、纯化及鉴定[J].中国实验诊断学,2012,16(1): 11-13. |